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Data were collected from surgical patients in the hos-
pital and on 4 occasions postdischarge. The incidence of
postdischarge surgical site infection was 8.46%. Strong evi-
dence showed that these infections caused minor addition-
al costs, which contradicts existing literature. We discuss
why previous studies might have overstated costs. 
Most cases of healthcare-acquired surgical site infec-tions (SSI) appear after discharge from hospital (1);
rates of postdischarge SSI between 2% and 14% have been
reported (2). Little is known of the costs of postdischarge
SSI, but 2 studies suggest that they are large (3–5) with
health services and patients incurring costs and subsequent
production losses. The combination of high frequency and
high cost suggests that programs that reduce the risks of
postdischarge SSI should be adopted, but decision makers
should assess the cost-effectiveness of additional preven-
tion efforts. This exercise requires valid estimates of the
change in costs and benefits from additional prevention
programs (6,7). Understanding the costs of postdischarge
SSI is therefore essential. The work completed so far is
valuable but demonstrates some methodologic weakness-
es. Plowman et al. (3,4) assessed only patient-reported
signs and symptoms of postdischarge SSI, and
Perencevich et al. (5) relied on routine healthcare records
for diagnosis/surveillance and matched case patients with
controls on only 3 confounding variables.
Our study assessed the costs of postdischarge SSI. We
adopted a societal perspective and included the costs
incurred by healthcare services, private costs, and produc-
tion losses. The research method was chosen to address the
suggested weaknesses of the studies of Plowman et al.
(3,4) and Perencevich et al. (5).
The Study
We recruited, in consecutive order, adults (>18 years of
age) admitted to 3 Australian hospitals in 2004 for knee or
hip prostheses, cardiovascular procedures, femoropopliteal
bypass grafts, or abdominal procedures, including abdom-
inal hysterectomies and lower segment caesarean sections.
Four infection-control research nurses recruited partici-
pants and collected data during the hospital admission
process and on 4 separate occasions after surgery by visit-
ing the patients in their homes (data collection is illustrat-
ed in the Figure). Monetary estimates of all costs were
made by multiplying frequency with a cost vector for the
item of service (9–12). Production losses were estimated
by comparing the presurgery level of (unwaged and
waged) productive activity with the actual level of
(unwaged and waged) productive activity achieved during
the 4 weeks postdischarge. These losses were converted to
a monetary value by using market prices for labor, approx-
imated by average pretax earnings (13). 
The question we address is whether postdischarge SSIs
independently affect costs. The specific cost outcomes we
seek to explain are listed in online Appendix 1 (available
from http://www.cdc.gov/ncidod/EID/vol12no05/05-1321
_app1.htm). Adjustment was made for other factors
believed to influence these cost outcomes (i.e., confound-
ing factors); these included the type of surgical procedure,
duration of surgery, American Society of Anesthesiologists
score, wound class, number of coexisting conditions,
length of hospital stay, whether patient was funded by the
public sector or private insurance, admitting hospital, sex,
age, ethnicity, patient’s socioeconomic status (14), whether
the patient was in waged employment, salary level and
health-related quality of life as measured by the SF-12v2
Health Survey (available from http://www.sf-36.org/
tools/sf12.shtml) scores at baseline and 4 weeks postdis-
charge. The complete set of explanatory variables avail-
able for analyses and the summary statistics are presented
in Table 1 and online Appendix 2 (available at http://
www.cdc.gov/ncidod/EID/vol12no05/05-1321_app2
.htm). Because the outcome variables were continuous and
linear, ordinary least squares regression was chosen to
model the independent effect of SSI on cost outcomes
(Table 2). See online Appendix 3 (available at http://www.
cdc.gov/ncidod/EID/vol12no05/05-1321_app3.htm) for a
description of the statistical analyses. 
The mean age of the 449 patients included in the analy-
ses was 63.65 years (SD 14.34), and 50.56% were women.
The mean length of hospital stay for the sample was 7.8
days (SD 8.68, median 6 days, interquartile range 4–8).
Thirty-eight of the 449 patients included in the study had a
diagnosis of SSI postdischarge, which indicates an inci-
dence of 8.46% for the 8-month period during which
patients were recruited. A higher proportion of persons
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with SSI (18.24%) compared to those without SSI (2.43%)
were readmitted to the hospital, but the mean lengths of
stay of the readmitted persons were similar, 16.57 days
versus 15.72 days, respectively. Summary statistics for all
variables are included in Table 1 and in online Appendix 2,
and the ICD-10 procedures for the 38 cases of SSI are
described in online Appendix 4 (available at http://www.
cdc.gov/ncidod/EID/vol12no05/05-1321_app4.htm).
No evidence was found of multicollinearity or interac-
tions between variables. However, none of the outcome
variables were normally distributed, and variance of the
error term was not constant (i.e., heteroscedastic), so all
models were estimated by using the Huber–White covari-
ance matrix (15). Results of the ordinary least squares
regressions are summarized in online Appendix 1. Strong
statistical evidence shows that postdischarge SSI inde-
pendently causes the following: 1.36 extra contacts with
community-based services with increased costs of $47.78;
6.46 days of additional antimicrobial drug therapy with
increased costs of $14.44; and an increase in total health
service costs of AU $74 (US $57) when the costs of read-
mission to the hospital are excluded and AU $123 (US
$94) when the costs of readmission to the hospital are
included. The strength of the relationship between SSI and
all other cost outcomes was not significant with the 95%
confidence interval crossing zero for all other models.
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Figure. The timing and nature of data collection. *Interview questions available from author on request. †Types of data collected from
patient hospital records available from author on request. ‡Variables collected from patient at each nurse visit are available from author
on request. CDC, Centers for Disease Control and Prevention; SSI, surgical site infection; AICA-NAB, Australian Infection Control
Association–National Advisory Board.
Conclusions
These results support the view that most SSIs first
appear after discharge from hospital, but we did not find
any evidence that postdischarge SSI causes substantial
economic costs even when costs are viewed from a socie-
tal perspective. These findings contradict Perencevich et
al. (5), who found the economic cost of a case of SSI diag-
nosed after discharge was almost 50-fold the estimate we
report here. Thus, what might explain this extreme discrep-
ancy in attributed costs? The study designs and research
methods differed. Compared to Perencevich et al. (5), we
used more control variables (described in Tables 1 and
Online Appendix 2 and listed below the table in Appendix
1). Might this extended set of control variables reduce bias
from omitted variables and so reduce the cost attributed to
SSI? Another factor might be the surveillance method.
Perencevich et al. (5) used automated record screening that
relied on accurate documentation of diagnostic, testing, or
treatment codes and pharmacy records. This process
resulted in 89 diagnoses among 4,571 patients, an inci-
dence rate of 1.9%. For our study, patients were recruited
before surgery and infection-control research-nurses visit-
ed the patients in their homes on 4 occasions after dis-
charge, during which time the wound was examined and
the definition of the Centers for Disease Control and
Prevention definition, modified by the Australian Infection
Control Association Inc., was applied (8). This method
yielded a much higher infection rate of 8.38%. One inter-
pretation is that the surveillance method used by
Perencevich et al. was not sensitive to all cases of postdis-
charge SSI. Instead, only those that generated certain data
items in the downstream electronic records were flagged,
and these may have been the most serious cases of SSI that
generated the greatest costs. This theory might be support-
ed by the higher rate of readmission among the patients
with cases of SSI in the Perencevich data (34%) compared
to the rate in our study (18%).
Of course, other factors may have an influence, such as
the case mix and socioeconomic characteristics of the par-
ticipants, the costs of the inputs to healthcare services (i.e.,
salaries for doctors and nurses), consumer preferences
(i.e., for more or less postdischarge care), and predefined
care protocols.
Also, our data only describe a 4-week period after sur-
gery and not the 8-week period considered by Perencevich
et al. (5). We recommend that readers interpret our results
carefully but nevertheless suggest that the economic costs
of SSIs that occur after hospital discharge are real but not
substantial.
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